Analogic announces FDA clearance for handheld Sonic Window ultrasound system Analogic announced that it has received 510k clearance from the FDA for the handheld Sonic Window ultrasound system, an imaging device for visualizing vasculature and guiding peripheral intravenous access. The ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral IVs. Initial evaluation by clinicians reveals that the Sonic Window incorporates the benefits of breakthrough ultrasound imaging technology with portability, making it an efficient tool to use in a clinical setting for the successful establishment of PIV in the patient with challenging IV access.
Analogic upgraded to Buy from Hold at Brean Capital Brean Capital upgraded Analogic to Buy with a $110 price target saying it expects the business to both uptick and be more predictable going into FY16. Brean sees the company's growth being led by ultrasound.